Search Results 361-370 of 21409 for anti-TNF drugs

  1. Neuromyelitis optica: New therapies offer hope - Mayo Clinic

    The Food and Drug Administration (FDA) has approved the use of three medications for the treatment of neuromyelitis optica spectrum disorder (NMOSD).

  2. Tofacitinib (Oral Route) Proper Use - Mayo Clinic

    This medicine should come with a Medication Guide. Read and follow the instructions carefully. Ask your doctor if you have any questions.

  3. Von Willebrand disease - Diagnosis & treatment - Mayo Clinic

    The estrogen hormones in birth control pills can boost von Willebrand factor and factor VIII activity. Clot-stabilizing medications. These anti-fibrinolytic ...

  4. Mayo Clinic Radio: Multiple sclerosis / nonsteroidal anti-inflammatory drugs / bone marrow transplant

    Mayo Clinic Radio: Multiple sclerosis / nonsteroidal anti-inflammatory drugs / bone marrow transplant. By. Jennifer O'Hara. February 27, 2017. Share this: Share ...

  5. Trimethobenzamide (Intramuscular Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Arrestin; Benzacot; Stemetic; Ticon; Tigan; Tribenzagan ...

  6. Clotrimazole (Topical Route) Proper Use - Mayo Clinic

    For topical dosage forms (cream, lotion, and solution):. Fungal infections (treatment):. Adults and children—Use two times a day, morning and evening. Missed ...

  7. Estrogen And Progestin Oral Contraceptives (Oral Route) Description and Brand Names - Mayo Clinic

    ... treatment of moderate acne only if the patient is at least 15 years old, has acne that has not improved with topical anti-acne medicines, has gotten ...

  8. Science Saturday: Researchers explore personalized approach to anti-obesity medications - Mayo Clinic News Network

    Acosta and a team of Mayo Clinic researchers set out to study anti-obesity medications based on obesity phenotypes to enhance weight loss. A phenotype is a set ...

  9. Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial - Mayo Clinic

    Intravitreal anti-inflammatory Therapy (MERIT) Trial will compare the relative efficacy and safety of intravitreal methotrexate, intravitreal ranibizumab, and ...

  10. Safety and Immune Response of the COVID 19 Vaccine in Patients with Inflammatory Bowel Disease - Mayo Clinic

    ustekinumab mono or combination therapy;; patients on mesalamine or no therapy. Group B (Low vaccine responders):. Anti-TNF monotherapy;; anti-TNF combination ...